GSK (GSK), a large British drug maker, is rallying 8% after reporting higher-than-expected fourth-quarter earnings per share and raising its long-term revenue guidance. GSK’s Beat-and-Raise Results ...

As a result, the company said it is targeting total sales of more than £40 billion by 2031, hiking its previous target of ...

About 800,000 Americans will have a heart attack or stroke this year. While heart disease can affect anyone, the risk substantially rises with age.

MRK provided 2025 adjusted EPS guidance of $8.88 to $9.03, while the giant drugmaker expects sales of $64.1 billion to $65.6 ...

Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...

FDA published two final guidance documents related to food allergens: Questions and Answers Regarding Food Allergens, ...

After repeated calls for action, the FDA has set a guideline for lead in baby food -- but it is not the end of the fight for safer food.

The alarm certainly sounded long and loud in 2022 when Abbott recalled Similac, Alimentum, and EleCare powdered infant formulas after an FDA investigation ...

If you are pregnant or nursing, talk with your health care professional about whether to enroll in pregnancy safety or ...

The FDA removed previously issued draft guidance on diversity in clinical trials from its website without public notice or ...

Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading key policies on artificial intelligence and software as a medical device.

Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading on policies involving artificial ...